Abstract

No AccessJournal of UrologyReview Article1 Jan 2022Editorial CommentThis article comments on the following:The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials Marwan Ali, and Ryan P. Smith Marwan AliMarwan Ali Male Reproductive Medicine and Surgery, University of Virginia, Charlottesville, Virginia More articles by this author , and Ryan P. SmithRyan P. Smith Male Reproductive Medicine and Surgery, University of Virginia, Charlottesville, Virginia More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002188.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 207(1), pp. 50–51 Reference 1. : A comparison of secondary polycythemia in hypogonadal men treated with clomiphene citrate versus testosterone replacement: a multi-institutional study. J Urol 2017; 197: 1127. Link, Google Scholar © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyAug 27, 2021, 12:00:00 AMThe Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials Volume 207Issue 1January 2022Page: 50-51 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Marwan Ali Male Reproductive Medicine and Surgery, University of Virginia, Charlottesville, Virginia More articles by this author Ryan P. Smith Male Reproductive Medicine and Surgery, University of Virginia, Charlottesville, Virginia More articles by this author Expand All Advertisement PDF DownloadLoading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.